New Key Statistics Module, Z-Score and F-Score
AMEX:ATNM Key Ratios
| Market Cap $ M | 40.24 |
| Enterprise Value $ M | -38.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.05 |
| Price/Sales | 430.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.39 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 27.30 |
| 5-y EBITDA Growth Rate % | 25.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.87 |
| EV-to-EBITDA | 0.83 |
| PEG | -- |
| Shares Outstanding M | 31.20 |
| Net Margin (%) | -50,512.35 |
| Operating Margin % | -55,504.94 |
| Pre-tax Margin (%) | -50,512.35 |
| Quick Ratio | 10.25 |
| Current Ratio | 10.25 |
| ROA % (ttm) | -47.50 |
| ROE % (ttm) | -99.37 |
| ROIC % (ttm) | -1,275.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.34 |
ATNM Number of Guru Trades
ATNM Volume of Guru Trades
Gurus Latest Trades with AMEX:ATNM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:ATNM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Actinium Pharmaceuticals Inc Insider Transactions
No Available Data
News about AMEX:ATNM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers